These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16463839)

  • 1. The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage.
    Pachl J; Haninec P; Tencer T; Mizner P; Houst'ava L; Tomás R; Waldauf P
    Acta Neurochir Suppl; 2005; 95():141-5. PubMed ID: 16463839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature.
    Agrawal A; Patir R; Kato Y; Chopra S; Sano H; Kanno T
    Minim Invasive Neurosurg; 2009 Feb; 52(1):5-8. PubMed ID: 19247898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of intraventricular sodium nitroprusside and thiosulfate for the treatment of cerebral vasospasm in the intensive care unit setting.
    Thomas JE; McGinnis G
    Stroke; 2002 Feb; 33(2):486-92. PubMed ID: 11823657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular sodium nitroprusside therapy: a future promise for refractory subarachnoid hemorrhage-induced vasospasm.
    Kumar R; Pathak A; Mathuriya SN; Khandelwal N
    Neurol India; 2003 Jun; 51(2):197-202. PubMed ID: 14571002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm.
    Raabe A; Zimmermann M; Setzer M; Vatter H; Berkefeld J; Seifert V
    Neurosurgery; 2002 May; 50(5):1006-13; discussion 1013-4. PubMed ID: 11950403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro therapy with dobutamine, isoprenaline and sodium nitroprusside protects vascular smooth muscle metabolism from subarachnoid haemorrhage induced cerebral vasospasm.
    Clark JF; Pyne GJ; Choutka J; Carrozzella JA; Khoury J; Broderick JP; Cadoux-Hudson TA
    Acta Neurochir (Wien); 2001; 143(7):721-8. PubMed ID: 11534694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm.
    Pathak A; Mathuriya SN; Khandelwal N; Verma K
    Br J Neurosurg; 2003 Aug; 17(4):306-10. PubMed ID: 14579895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.
    Hänggi D; Eicker S; Beseoglu K; Behr J; Turowski B; Steiger HJ
    Cent Eur Neurosurg; 2009 May; 70(2):61-7. PubMed ID: 19711257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Case of Hyperacute Onset of Vasospasm After Aneurysmal Subarachnoid Hemorrhage and Refractory Vasospasm Treated with Intravenous and Intraventricular Nitric Oxide: A Mini Review.
    Ehlert A; Manthei G; Hesselmann V; Mathias K; Bein B; Pluta R
    World Neurosurg; 2016 Jul; 91():673.e11-8. PubMed ID: 27109628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical usefulness of transcranial Doppler ultrasound imaging in the diagnosis of cerebral vasospasm in subarachnoid haemorrhage. A validation study].
    Scherle-Matamoros CE; Perez-Nellar J; Castro-Jimenez M
    Rev Neurol; 2008 Sep 16-30; 47(6):295-8. PubMed ID: 18803155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical application of dexamethasone to prevent cerebral vasospasm after aneurysmal subarachnoid haemorrhage: a pilot study.
    Fei L; Golwa F
    Clin Drug Investig; 2007; 27(12):827-32. PubMed ID: 18020540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.
    Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M
    J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimodipine for the prevention of cerebral vasospasm after subarachnoid hemorrhage in 12 children.
    Heffren J; McIntosh AM; Reiter PD
    Pediatr Neurol; 2015 Mar; 52(3):356-60. PubMed ID: 25585913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the calcium-antagonist nimodipine for the prevention of vasospasm after aneurysmal subarachnoid haemorrhage. A prospective transcranial Doppler ultrasound study.
    Seiler RW; Grolimund P; Zurbruegg HR
    Acta Neurochir (Wien); 1987; 85(1-2):7-16. PubMed ID: 2955675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Course and Monitoring Parameters After Continuous Interventional Intra-Arterial Treatment in Patients with Refractory Cerebral Vasospasm.
    von der Brelie C; Doukas A; Stopfer A; Larsen N; Mehdorn M; Synowitz M; Jansen O
    World Neurosurg; 2017 Apr; 100():504-513. PubMed ID: 28131927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.
    Mocco J; Mack WJ; Kim GH; Lozier AP; Laufer I; Kreiter KT; Sciacca RR; Solomon RA; Mayer SA; Connolly ES
    J Neurosurg; 2002 Sep; 97(3):537-41. PubMed ID: 12296636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.